Home page > About us
 

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

About Chiesi Group

Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.

By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. Since 2019, Chiesi is the world’s largest biopharmaceutical group to be certified B Corp, meaning that its sustainability efforts are measured and assessed by the most ambitious global standards. The company aims at becoming net-zero by 2035.

With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 30 countries, and counts more than 6,000 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.

 

For further information please visit www.chiesi.com

 

Contacts for media:

Carla Arrieta Martinez

Head of Global External Communication & Media Relations

Tel:    +39 340 8879754

Email   c.arrieta@chiesi.com

 

Alessio Pappagallo

Press Office Manager

Tel:    +39 339 589483

Email   a.pappagallo@chiesi.com